Literature DB >> 36272978

Molecular basis for isoform-selective inhibition of presenilin-1 by MRK-560.

Xuefei Guo1, Yumeng Wang1, Rui Zhou2, Jiayao Zhou1, Chen Jin1, Jiaoni Wang1, Bojun Jia1, Dan Jing3,4,5, Chuangye Yan1, Jianlin Lei1, Yigong Shi6,7,8,9.   

Abstract

Inhibition of γ-secretase activity represents a potential therapeutic strategy for Alzheimer's disease (AD). MRK-560 is a selective inhibitor with higher potency for Presenilin 1 (PS1) than for PS2, the two isoforms of the catalytic subunit of γ-secretase, although the underlying mechanism remains elusive. Here we report the cryo-electron microscopy (cryo-EM) structures of PS1 and PS2-containing γ-secretase complexes with and without MRK-560 at overall resolutions of 2.9-3.4 Å. MRK-560 occupies the substrate binding site of PS1, but is invisible in PS2. Structural comparison identifies Thr281 and Leu282 in PS1 to be the determinant for isoform-dependent sensitivity to MRK-560, which is confirmed by swapping experiment between PS1 and PS2. By revealing the mechanism for isoform-selective inhibition of presenilin, our work may facilitate future drug discovery targeting γ-secretase.
© 2022. The Author(s).

Entities:  

Year:  2022        PMID: 36272978     DOI: 10.1038/s41467-022-33817-5

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   17.694


  1 in total

1.  Evidence that enzyme processivity mediates differential Aβ production by PS1 and PS2.

Authors:  Sean A Pintchovski; Dale B Schenk; Guriqbal S Basi
Journal:  Curr Alzheimer Res       Date:  2013-01       Impact factor: 3.498

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.